Find a Test

Search by Test Name:

#    A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

IgG, CSF

Test Code: 17188 CPT Code: 82784
Specimen Type: CSF
Sample Volume: 2.0 mL
Transport Condition: Refrigerated condition
Specimen Rejection Criteria: Nil
Methodology: Nephelometry
Special Requirements: Clinical history is required
Clinical Significance:

Inflammatory diseases of the central nervous system (CNS) like multiple sclerosis, neurosyphilis, acute inflammatory polyradiculoneuropathy, subacute sclerosing panencephalitis etc. results in elevation of IgG levels in the cerebrospinal fluid (CSF) of patients. This is due to local central nervous system synthesis of IgG. This assay can be used in evaluation of such CNS inflammatory diseases.

Run Day: Mon, Thurs
Reporting Day: 3rd day

Immuno Electrophoresis

Test Code: 6158 CPT Code: 86320
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 3.0 mL
Transport Condition: Refrigerated/ frozen condition
Specimen Rejection Criteria: Gross hemolysis
Methodology: Electrophoresis
Special Requirements: No special precautions needed
Clinical Significance:

This assay is useful for diagnosing & monitoring patients with monoclonal gammopathies. Protein electrophoresis alone is not considered an adequate screening test for monoclonal gammopathies.

Run Day: Sun, Wed
Reporting Day: Next day

Immunofixation Electrophoresis, Urine

Test Code: 17154 CPT Code: 86335
Specimen Type: 24 hrs urine
Sample Volume: 10 mL
Transport Condition: Frozen condition
Specimen Rejection Criteria: Nil
Methodology: Immunoelectrophoresis
Special Requirements: Clinical history is required.
Clinical Significance:

Monoclonal gammopathies indicate a clonal expansion of plasma cells or mature B lymphocytes.Immunotyping of monoclonal proteins in the urine done by immunofixation electrophoresis (IFE) identifies the monoclonal immunoglobulin heavy-chain (gamma, alpha, mu, delta, or epsilon) and/or light-chain type (kappa or lambda). This aids in the diagnosis of monoclonal gammopathies.

Run Day: Mon, Thurs
Reporting Day: Same day

Immunoglobulin A (IgA), Serum

Test Code: 1196 CPT Code: 82784
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 10 mL
Transport Condition: Room temperature
Specimen Rejection Criteria: Grosshemolysis and hyperlipemic
Methodology: Immunoassay
Special Requirements: No special precautions needed
Clinical Significance:

This assay is useful for diagnosing & monitoring patients with monoclonal gammopathies. Protein electrophoresis alone is not considered an adequate screening test for monoclonal gammopathies.

Run Day: Daily
Reporting Day: 2nd day

Immunoglobulin E (IgE), Serum

Test Code: 4631 CPT Code: 82785
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated condition
Specimen Rejection Criteria: Gross hemolysis
Methodology: Immunoassay
Special Requirements: No special precautions needed
Clinical Significance:

For diagnosis of allergic diseases. A normal IgE level does not exclude the possible presence of an allergic disorders.

Run Day: Daily
Reporting Day: Same day

Immunoglobulin IgA, Total, Serum

Test Code: 6260 CPT Code: 82784
Specimen Type: Serum (yellow-top tube)
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated condition
Specimen Rejection Criteria: Grosshemolysis and hyperlipemic
Methodology: Immunoturbidimetry
Special Requirements: Clinical history is required
Clinical Significance:

This assay is useful for detecting or monitoring monoclonal gammopathies and immune deficiencies.

Run Day: Daily
Reporting Day: Next day

Immunoglobulin IgG, Total, Serum

Test Code: 1191 CPT Code: 82784
Specimen Type: Serum (yellow-top tube)
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated condition
Specimen Rejection Criteria: Grosshemolysis and hyperlipemic
Methodology: Immunoturbidimetry
Special Requirements: No special precautions needed
Clinical Significance:

In normal serum, about 80% is immunoglobulin G (IgG).
Elevations of IgG may be due to polyclonal or monoclonal immunoglobulin production. Monoclonal elevations of IgG characterize monoclonal gammopathies such as multiple myeloma, primary systemic amyloidosis, monoclonal gammopathy of undetermined significance, and related disorders. Monoclonal gammopathies may lead to a spike in the gamma globulin zone seen on serum protein electrophoresis.
Decreased immunoglobulin levels are found in patients with primary or secondary immune deficiencies.

Run Day: Daily
Reporting Day: Next day

Immunoglobulin M (IgM), Serum

Test Code: 1193 CPT Code: 82784
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated condition
Specimen Rejection Criteria: Gross hemolysis
Methodology: Immunoassay
Special Requirements: No special precautions needed
Clinical Significance:

This assay is useful for diagnosing & monitoring patients with monoclonal gammopathies. Protein electrophoresis alone is not considered an adequate screening test for monoclonal gammopathies.

Run Day: Daily
Reporting Day: 2nd day

Immunoglobulin Profile (IgA, IgG, IgM)

Test Code: 1186 CPT Code: 82784
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 5.0 mL
Transport Condition: Room temperature
Specimen Rejection Criteria: Grosshemolysis and hyperlipemic
Methodology: Immunoassay
Special Requirements: No special precautions needed
Clinical Significance:

This assay is useful for diagnosing & monitoring patients with monoclonal gammopathies. Protein electrophoresis alone is not considered an adequate screening test for monoclonal gammopathies.

Run Day: Daily
Reporting Day: 2nd day

Immunohistochemistry, Actin

Test Code: 3795 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, AFP

Test Code: 3796 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, CD 1 A

Test Code: 3797 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, CD 117

Test Code: 3798 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, CD 15

Test Code: 3799 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, CD 20

Test Code: 3800 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, CD 3

Test Code: 3805 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 3rd day

Immunohistochemistry, CD 30

Test Code: 3803 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, CD 34

Test Code: 3804 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, CD 43

Test Code: 3806 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, CD 45 (LCA)

Test Code: 3807 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, CD 68

Test Code: 3801 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, CD 99

Test Code: 3802 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 3rd day

Immunohistochemistry, CEA

Test Code: 3808 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, Chromogranin A

Test Code: 3809 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, CK

Test Code: 3810 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, Cytokeratin

Test Code: 3811 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, Desmin

Test Code: 3812 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, EA

Test Code: 3813 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, EMA

Test Code: 3814 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, Estrogen Receptor

Test Code: 3815 CPT Code: 88360
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

Estrogen and progesterone receptor assays are routinely performed on breast carcinomas to assess responsiveness to endocrine therapy and prognosis

Run Day: Daily
Reporting Day: 3rd day

Immunohistochemistry, Factor VIII

Test Code: 3816 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, GFAP

Test Code: 3817 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, GFR

Test Code: 3818 CPT Code: 88360
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, HCG

Test Code: 3819 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, HER2/ neu

Test Code: 2892 CPT Code: 88360
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Histochemical stain
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 2nd day

Immunohistochemistry, HMW Cytokeratin

Test Code: 3821 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, HPV

Test Code: 3822 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, Ki-67 Antigen

Test Code: 3823 CPT Code: 88360
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, MART1(Melan-A)

Test Code: 3824 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, NSE

Test Code: 3825 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, PLAP

Test Code: 3826 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, Progesterone Receptors

Test Code: 3827 CPT Code: 88360
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

Estrogen and progesterone receptor assays are routinely performed on breast carcinomas to assess responsiveness to endocrine therapy and prognosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, PSA

Test Code: 3828 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, S-100

Test Code: 3829 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

S-100 is strongly expressed in melanomas, salivary gland tumors, and Schwann cell tumors

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, Standard

Test Code: 2891 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: Specimen in 10% buffered formalin
Transport Condition: Room temperature
Specimen Rejection Criteria: Autolyzed Tissue
Methodology: Microscopic
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

The nature of possible underlying disease can be ruled out/confirmed through histopathological examination

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, Synaptophysin

Test Code: 3830 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, TTF

Test Code: 3831 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunohistochemistry, Vimentin

Test Code: 3832 CPT Code: 88342
Specimen Type: Tissue
Sample Volume: formalin-fixed, paraffin-embedded tissue block
Transport Condition: Room temperature
Specimen Rejection Criteria: Received frozen
Methodology: Immunohistochemistry
Special Requirements: Clinical history and sample site are essential
Clinical Significance:

For histopathological diagnosis

Run Day: Daily
Reporting Day: 4th day

Immunoreactive Trypsinogen (Neonatal Screening)

Test Code: 13733 CPT Code: 83520
Specimen Type: Dry Blood Spot
Sample Volume: 2 spots
Transport Condition: Refrigerated condition
Specimen Rejection Criteria: Nil
Methodology: Enzyme immunoassay
Special Requirements: Complete clinical history including birth date & birth time. (2-8 days accepted, upto 1 month with disclaimer comment)
Clinical Significance:

Trypsinogen is a proenzyme, an inactive precursor to the proteolytic enzyme trypsin. Normally, trypsinogen is produced in the pancreas and transported tothe small intestine. Infants (1 to 2 weeks of age) with cystic
fibrosis, show increased levels of immunoreactive trypsinogen in the neonatal heal-prick test. It is currently the best screening test for cystic fibrosis but cannot be done after the first few weeks
of life since it falls as pancreatic insufficiency develops.

Run Day: Mon, Thurs
Reporting Day: Next day

Infectious Disease Screening (HIV 1 & 2 Antibodies, HCV Antibodies, HBsAg)

Test Code: 6250 CPT Code: Use individual CPTCodes
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 5.0 mL
Transport Condition: Refrigerated/ frozen condition
Specimen Rejection Criteria: Hemolysis/ received room temperature
Methodology: Immunoassay
Special Requirements: No special precautions needed
Clinical Significance:

See individual assays

Run Day: Daily
Reporting Day: Same day

Infliximab Antibody, Serum

Test Code: 16402 CPT Code: 82397
Specimen Type: Serum (yellow-top tube)
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Frozen condition
Specimen Rejection Criteria: Grosshemolysis and hyperlipemic
Methodology: Chemiluminescence
Special Requirements: Clinical details including drug history is required
Clinical Significance:

Infliximab is a chimeric immunoglobulin (IgG1 kappa) targeting tumor necrosis factor-alpha (TNF-a), and is currently used for
the treatment of multiple inflammatory conditions. Infliximab binds to soluble TNF-a and transmembrane homotrimers.Testing for antibodies to infliximab (ATI) is recommended if there is a loss of response to infliximab.

Run Day: Daily
Reporting Day: 20th day

Infliximab Drug Level, Serum

Test Code: CPT Code: 80299
Specimen Type: Serum (red-top tube)
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Frozen preferred/ refrigerated condition
Specimen Rejection Criteria: Grosshemolysis and hyperlipemic. Plasma, whole blood, SST tubes
Methodology: Immunoassay
Special Requirements: Clinical details including drug history is required
Clinical Significance:

Infliximab is a chimeric immunoglobulin (IgG1 kappa) targeting tumor necrosis factor-alpha (TNF-a), and is currently used
for the treatment of multiple inflammatory conditions. Evaluation of infliximab concentrations may be of value for all inflammatory diseases for which it
is prescribed. Primary indications for testing of infliximab include loss of response, partial response on initiation of therapy, autoimmune or hypersensitivity reactions, primary nonresponse, reintroduction after drug holiday, endoscopic/computed tomography enterography recurrence (in inflammatory bowel disease), and acute infusion reactions. Low trough concentrations may be correlated with loss of response to infliximab. Antibodies to Infliximab is also recommended if there is loss of response to the drug.

Run Day: Daily
Reporting Day: 20th day

Influenza (A & B), Nasal Swab

Test Code: 3644 CPT Code: 87254,87804
Specimen Type: Nasal ornasopharyngeal swab
Sample Volume: 1 swab
Transport Condition: Room temperature
Specimen Rejection Criteria: Sample in transport media or frozen sample
Methodology: Immunochromatography
Special Requirements: No special precautions needed
Clinical Significance:

Influenza is associated with high morbidity and mortality, is preventable by vaccination/ chemoprophylaxis and is treatable by specific antivirals.
The laboratory diagnosis of influenza can help guide the clinical management of influenza patients. Patients with lower respiratory tract illness, especially children and adults with medical conditions increasing their risk for developing complicated influenza, should be considered for rapid influenza virus diagnostic testing. This assay is a qualitative analysis detecting Influenza virus A type and B type antigens in the nasopharyngeal samples using immunochromatography. With this test method, influenza virus infection status can be discriminated with availability of results in a clinically relevant time frame to complement the use of antiviral medications for treatment and chemoprophylaxis.

Run Day: Daily
Reporting Day: Same day

Inhibin B, Serum

Test Code: 6868 CPT Code: 83520
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated/ frozen condition
Specimen Rejection Criteria: Gross hemolysis
Methodology: Immunoassay
Special Requirements: No special precautions needed
Clinical Significance:

Monitoring of patients with granulosa cell tumors and epithelial mucinous-type tumors of the ovary known to overexpress inhibin B.

Run Day: Thurs
Reporting Day: 2nd day

Insulin like Growth Factor -1 (IGF-1)

Test Code: 7083 CPT Code: 84305
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated/ frozen condition
Specimen Rejection Criteria: Gross hemolysis
Methodology: Immunoassay
Special Requirements: No special precautions needed
Clinical Significance:

IGF-I (somatomedin-C) measurements are useful in the evaluation of growth deficiencies and acromegaly.

Run Day: Wed
Reporting Day: Next day

Insulin Resistance Test (3 samples)

Test Code: 6271 CPT Code: 83525
Specimen Type: Serum collected in yellow top tube and plasma collected in Grey top tube
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated/ frozen condition
Specimen Rejection Criteria: Gross hemolysis
Methodology: ECLIA
Special Requirements: Fasting sample, 1 hour and 2 hour sample
Clinical Significance:

For diagnosis and monitoring of diabetes and insulin-secreting tumors.

Run Day: Daily
Reporting Day: Same day

Insulin-Like Growth Factor Binding Protein-3 (IGFBP3), Serum

Test Code: 22034 CPT Code: 83520
Specimen Type: Serum (yellow-top tube)
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated/ frozen condition
Specimen Rejection Criteria: Gross hemolysis
Methodology: Chemiluminescence
Special Requirements:
Clinical Significance:

Insulin-like growth factor binding protein3 (IGFBP3) is an amino acid peptide produced by the liver. It is the most abundant of
a group of IGFBPs that transport, and control bioavailability and half-life of insulin-like growth factors (IGFs), particularly IGF1, the major mediator of the anabolic and growth promoting effects of growth hormone. This assay aids in diagnosing growth disor-
ders, diagnosing adult growth hormone deficiency, monitoring of recombinant human growth hormone treatment. It can
be also used as an adjunct to insulin-like growth factor 1 and growth hormone in the diagnosis and follow-up of acromegaly and gigantism.

Run Day: Wed, Fri
Reporting Day: Same day

Insulin, 1h Post Prandial

Test Code: 7140 CPT Code: 83527
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated/ frozen condition
Specimen Rejection Criteria: Gross hemolysis
Methodology: ECLIA
Special Requirements: No special precautions needed
Clinical Significance:

For diagnosis and monitoring of diabetes and insulin-secreting tumors.

Run Day: Daily
Reporting Day: Same day

Insulin, Fasting

Test Code: 479 CPT Code: 83525
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated/ frozen condition
Specimen Rejection Criteria: Gross hemolysis
Methodology: ECLIA
Special Requirements: 12 hrs of fasting
Clinical Significance:

For diagnosis and monitoring of diabetes and insulin-secreting tumors.

Run Day: Daily
Reporting Day: Same day

Insulin, Free

Test Code: 4871 CPT Code: 83527
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated/ frozen condition
Specimen Rejection Criteria: Gross hemolysis
Methodology: ECLIA
Special Requirements: Fasting recommended
Clinical Significance:

For diagnosis and monitoring of diabetes and insulin-secreting tumors.

Run Day: Daily
Reporting Day: 16th day

Insulin, Post Prandial

Test Code: 1317 CPT Code: 83527
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated/ frozen condition
Specimen Rejection Criteria: Gross hemolysis
Methodology: ECLIA
Special Requirements: No special precautions needed
Clinical Significance:

For diagnosis and monitoring of diabetes and insulin-secreting tumors.

Run Day: Daily
Reporting Day: Same day

Intrinsic Factor Antibodies, IgG, Serum

Test Code: 14550 CPT Code: 86340
Specimen Type: Serum (yellow-top tube)
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Frozen
Specimen Rejection Criteria: Gross hemolysis
Methodology: Enzyme immunoassay
Special Requirements: This test should not be ordered on patients who have received vitamin B12 injection within the last 2 weeks.
Clinical Significance:

Intrinsic factor binds the free vitamin B12 and carries it to receptors on the ileal mucosa facilitating its absorption. Most pernicious anemia patients have autoantibodies against gastric parietal cells or intrinsic factor, with the latter being highly specific. This assay aids in confirming the diagnosis of pernicious anemia.

Run Day: Fri
Reporting Day: Same day

Intrinsic Factor Antibodies, Serum

Test Code: 367 CPT Code: 86340
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated/ frozen condition
Specimen Rejection Criteria: Received room temperature
Methodology: Immunoassay
Special Requirements: No special precautions needed
Clinical Significance:

Intrinsic factor, produced by cells lining the stomach, binds vitamin B12 (cyanocobalamin) to facilitate absorption of the vitamin B12. Blocking antibodies impedes the action of intrinsic factor as observed in approximately half of the patients who develop pernicious anemia.

Run Day: Fri
Reporting Day: Next day

Iron Deficiency Anemia Profile (TIBC, Serum Iron, % Transferrin Saturation, CBC, PBF, Ferritin)

Test Code: 6249 CPT Code: Use individual CPTCodes
Specimen Type: Whole blood in a lavender-top (EDTA) tube, serum collected in a yellow-top tube
Sample Volume: Whole blood - 3.0 mL, serum- 3.0 mL
Transport Condition: Refrigerated condition
Specimen Rejection Criteria: Gross hemolysis
Methodology: Cell counter, microscopy, spectrophotometry, immunoassay
Special Requirements: No special precautions needed
Clinical Significance:

See individual assays

Run Day: Daily
Reporting Day: Same day

Iron, Total, Serum

Test Code: 300 CPT Code: 83540
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated condition
Specimen Rejection Criteria: Gross hemolysis
Methodology: Spectrophotometry
Special Requirements: No special precautions needed
Clinical Significance:

Serum measurements are useful in the diagnosis of iron deficiency and hemochromatosis

Run Day: Daily
Reporting Day: Same day

Islet Cell Antibodies, Serum

Test Code: 368 CPT Code: 86341
Specimen Type: Serum collected in a yellow-top tube
Sample Volume: 3.0 mL (1.0mL - min)
Transport Condition: Refrigerated condition
Specimen Rejection Criteria: Gross hemolysis
Methodology: Immunoassay
Special Requirements: No special precautions needed
Clinical Significance:

Islet cell antibodies measurement is a sensitive means to assess risk and predict onset of type 1 diabetes. There is a direct correlation between the antibodies titer and the severity of the autoimmune process.

Run Day: Wed
Reporting Day: Next day